Packaging Digest is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Packaging mistake results in voluntary recall of cold medicine

Packaging mistake results in voluntary recall of cold medicine
Dayquil blister pack, pharmaceutical packaging, recall

Vicks DayQuil Cold & Flu LiquiCaps
The absence of a child-resistant backing for blister packs in boxes of Vicks DayQuil Cold & Flu 24-Count LiquiCaps Bonus Pack in the U.S. has resulted in a voluntary recall of the product by the Procter & Gamble Co. The company reports that no accidental ingestion by children has been reported with this product, and the medication itself is safe for use when taken as directed.

Nevertheless, the company is taking the action because the packaging does sport label statements indicating that the product is in child-resistant packaging and Vicks DayQuil Cold & Flu LiquiCaps are not formulated for consumption by children younger the 12, unless recommended by a physician.


P&G states that the lack of child-resistant packaging means it is possible that a child could gain access to the medicine, and the company is urging consumers to stop using the recalled product. If consumers continue to use the product, the company is urging that extra care is taken to keep it out of the reach of children. This medicine could cause serious health problems or death to a child if accidentally swallowed.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish